infection' and appears to result from a combination of decreased platelet and impaired platelet production.2-6 The platelet count generally improves promptly after reticulo-endothelial cell suppression or ablation, suggesting an immunologic etiology, or within 1 week after anti-HIV-1 treatment with azidothymidine (AZT),536 suggesting megakaryocyte suppression, possibly due to the invasion of megakaryocytes (MGKs) with HIV-1. The evidence that MGK can be directly infected by HIV-I is supported by morphologic abnormalities of megakaryocytes,' the detection of HIV-1 viral mRNA in some MGKs of HIV-seropositive individuals,' the susceptibility of MGK cell lines in culture to productive infection with H1V-1,9 decreased MGK precursors," and improvement of impaired platelet turnover after treatment with AZT, whereas decreased platelet survival remains un~h a n g e d .~ However, a mode of entry for the HIV-I virus has not been established and HIV-1 viral antigens have not been detected on human MGK isolated from HIV-1 -infected patients.
and, if expressed as an integral part of the cell surface of MGKs, it could provide a portal of entry for the virus. However, the presence of the previously reported antigen could represent a nonfunctioning CD4 molecule, a cross-reacting epitope, or passive adsorption ofsoluble antigen onto the cell surface rather than synthesis and insertion of a functional receptor on the MGK membrane surface. Such adsorption phenomena have been reported for the T-cell antigen CD8 on thymocytes15 and for HLA antigens on platelets. 16 In this study, we provide evidence for a functional CD4 
MATERIALS AND METHODS
Normal human bone marrow specimens were obtained from discarded orthopedic surgical specimens (hip surgery) and were resuspended in CATCH medium." The tissue was gently pipetted with a 12-mL plastic syringe through an 18-gauge needle until a single cell suspension was obtained. The samples were then underlaid with an equal volume of Ficoll-Hypaque (1.077 g/mL: Sigma, St Louis, MO) and centrifuged at 2.000~ for 20 minutes at room temperature. The cells on the interface were collected, washed, resuspended in CATCH, underlaid with an equal volume of 3 8 8 isosmotic Percoll (Pharmacia, Piscataway. NJ) in CATCH medium, and centrifuged at 2,OOOg at 4°C for 20 minutes. The cells at the interface were again isolated, washed, and used for in situ hybridization and binding experiments (see below).
The CHRF-288 MGK line was kindly supplied by Dr M. Lieberman (University of Cincinnati Medical Center. Cincinnati. OH). This cell line was obtained from a patient with megakaryoblastic leukemia.I7 These cells are unique in that they have characteristic markers for MGKs and platelets, yet do not express the erythroid markers glycophorin A and hemoglobin, the myeloid marker myeloperoxidase, or markers for T and B cells.I7
Synthesis of' Radiolabeled Probe,fi,r CD4 mRNA
The plasmid pSP65.T4.8 was obtained from Dr D. Littman (University ofCalifornia. San Francisco, CA). It contains a 3-kb sequence that encodes the entire T4 (CD4) cDNA in the antisense orientation. An RNA probe was synthesized by linearizing the plasmid with Xba I (Boehringer Mannheim, Indianapolis. IN) and incubating it with SP6 RNA polymerase in the presence of transcription buffer, 10 mmol/L dithiothreitol (DTT), ribonuclease inhibitor, 0.5 mmol/L . The DNA template was digested with DNase l (RQI, Rnase free) in the presence of ribonuclease inhibitor and I mg/mL ofcarrier RNA. After removal of enzyme proteins by extraction with phenol/chloroform. the solution was made 2 mol/L ammonium acetate and the riboprobe precipitated with 100% ethanol in dry ice. The pellet was washed twice with 70% ethanol. dried, resuspended in 5 pL of 50 mmol/L DTT, and stored at -20°C until use. The probes were used within 2 days. Between IO* and 2 X IO' cpm were incorporated into each probe. All reagents were purchased from Promega (Madison, WI) and incubations were performed at 37°C.
The plasmid PJL-3 GEM, encoding a fragment of murine interleukin-3 (IL-3). was used as a negative control. It was provided by Dr S. Gillis of lmmunex Corp (Seattle, WA).
In Situ Ifybridizarion
Bone marrow cells were resuspended in CATCH media at a concentration of 2 to 3 X 10'/mL and applied on an area of 20 mm' over a slide coated with 3-aminopropyltriethoxysilane (Digene, Silver Spring. MD). After incubation in a humidified chamber at room temperature for 30 minutes, the slides were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS) for 20 minutes. In situ hybridization was then performed as previously described." Diethylpyrocarbonate (DEPC) was included in all of the buffers and was also present in the water used to wash the glassware required for these experiments. In selected experiments. immunocytochemistry was performed for MGK glycoprotein (GP) llla (see below). Kodak NTB-2 emulsion (Eastman Kodak. Rochester. NY) was used to coat the slides for autoradiography. The slides were exposed from 5 to 2 I days at 4°C and were counterstained with Giemsa.
Proviral DNA Assriy$)r 1111'-I CHRF-288 cells were divided into I-mL aliquots of I X IO6 cells/ mL. Ten microliters of Leu3a (Becton Dickinson. San Jose. CA) was added to I aliquot and IO pL of media was added to another. Both aliquots were incubated for 15 minutes at room temperature. The cells were then washed three times with Hanks' Balanced Salt Solution. One milliliter of supernatant from an HIV-IIIIR-infected cell line (HBP-9) that was filtered through a 0.22 pm filter was added to each aliquot for 30 minutes. The cells were then washed three times and placed at 37OC overnight. The next day the cells were washed five times and centrifuged to a pellet for processing for the polymerase chain reaction (PCR). Another aliquot ofCHRF-288 cells was washed and pelleted and used for a negative control.
The cell pellet was lysed by adding equal volumes of a solution incubated at 56°C for 2 hours and then at 95°C for 15 minutes. Tenmicroliter aliquots were added to 90-pL aliquots of PCR reaction buffer containing the primer pair (see below) at concentrations suggested by the manufacturer (Cetus/Perkin-Elmer, Norwalk, CT), with a final magnesium concentration of 2.5 mmol/L. In addition, bovine serum albumin was included in the reaction mixture at a concentration of 50 pg/mL. The mixture was subjected to I cycle of heating to 95°C for 2 minutes, followed by incubation at 80°C for 8 minutes. It was then followed by 30 cycles of annealing performed at 53°C (2 minutes), TAQ polymerase-mediated chain extension at 72°C (1 minute), and denaturation at 94°C ( I minute). A final annealing step followed by a prolonged extension step for 7 minutes completed the amplification.
The primer pair SK38/39, which encompasses the core region (gag 1551-1665), was used for sample amplification." The mixture was tested for the presence of HIV-1 DNA using a liquid hybridization protocol. Thirty microliters of the mixture is hybridized with I O pL of a cocktail containing 4 pL of 1.5 mol/L NaCI, a '*P-end-labeled SKI9 probe located at gag 1595-1635 (250,000 cpm/sample), and Tris-EDTA for at least 0.5 hours at 55°C and then electrophoresed through an 8% polyacrylamide gel and detected by autoradiography. The presence of HIV-1-DNA was associated with a displaced larger molecular weight band in the same area as the positive control of the probe alone. All assays included 1 positive and 2 negative controls. The DNA and reaction mixture preparation was routinely performed in separate rooms from where the hybridization assay was performed to reduce the risk of amplicon contamination.
HZV-lp24 Secretion
HBP-9 (CD4+) T cells or CHRF-288 MGK ( I X IO6) were incubated with either 0 or 10 pg of Leu3a in 1 mL of RPMI at room temperature for 30 minutes. The cells were washed, pelleted, and incubated with 0.5 mL of cell-free HIV-IIIIB for 30 minutes. Cells were rewashed, pelleted, and incubated with 1. I mL of RPMI for 9 days at 37°C. Aliquots were removed and assayed for p24 with an enzyme-linked immunosorbent assay (ELISA) kit provided by Coulter (Hialeah, FL).
Antibodies
For immunocytochemical staining, we used the murine monoclonal antibody (MoAb) LK-6 (IgGI, K IgG subclass), which was raised in our laboratory by Dr L.-X. Liu and has a high affinity for both native and denatured platelet/MGK GPIIIa. For binding and blocking experiments, we used a fluorescein-conjugated MoAb against the GPIIb/GPIIIa complex (CD4la, clone P2, mouse IgG,), purchased from AMAC (Westbook, ME). Unconjugated anti-CM (Leu 3a, clone SK3, mouse IgG,) was purchased from Becton Dickinson. Sheep antisera directed against gp I20 of HIV-1 (Lot DV- 0 12) . . mouse IgG,) was purchased from Becton Dickinson for use as a control.
Immunocytochemistry
Immunocytochemical staining of GPIIIa (a major platelet and MGK surface antigen) was performed in hybridization studies by incubating the slides in a moist chamber at room temperature with IO pg/mL of Ab LK-6 in PBS for 45 minutes. The samples were washed and incubated with a 1:60 dilution of goat antimouse IgG (Fc domain) conjugated to alkaline phosphatase. Enzymatic activity was detected by using an alkaline phosphatase detection kit with fast red violet (Sigma).
Immunofluorescence
Two-color immunofluorescence analysis was performed as described previously'2 using fluorescein (FL)-conjugated and PE-conjugated antibodies. Staining was performed at 4°C for approximately 30 minutes, unless otherwise noted.
DNA Staining
bination with two-color immunofluorescence to stain DNA.
The DNA dye 7-aminoactinomycin D (7-AAD) was used in com-
Binding Experiments
Percoll-enriched bone marrow cells were resuspended in RPMI 1640 (GIBCO, Grand Island, NY) and mixed with equal volumes of supernatant from an HIV-1-infected H9 cell line grown in RPMI/ 10% fetal calf serum (FCS). The HIV-1 used was a patient isolate. One milliliter of supernatant contained a P24 antigen content of 20 to 50 ng/mL. Cells were incubated with HIV-I at 4°C for 30 minutes, washed, resuspended at a concentration of approximately 2 X IO7, and stained for 30 minutes with either mouse anti-gpl20 or sheep anti-gp120. When mouse Ab was used, the secondary Ab was goat F(ab')* anti-MIgG conjugated to PE. When the primary Ab was from sheep, rabbit antisheep IgG coupled to biotin was used, followed by 15 minutes of incubation with streptavidin conjugated to PE. To block potentially unoccupied binding sites on the secondary Abs, all samples were resuspended in 10% normal mouse serum for IO minutes before being stained with CD41 conjugated to FL. The specimens were then analyzed by flow cytometry.
For blocking experiments, the samples were preincubated at 4°C for 30 minutes with either Leu3a, Leu2a, rCD4 (0.1 to IO pg/IOO p L cell suspension), Leu2a ( I pg), or normal human Fab (1 pg, molecular weight f 50 Kd), and then mixed with HIV-l-infected supernatant and stained as described above. Soluble rCD4 was obtained from the National Institutes of Allergy and Infectious Diseases, AIDS Research and Reference Reagent Program (Lot no. 55-89-ABT14).
Flow Cytometry
A Becton Dickinson FACScan cytometer equipped with a 15-mW argon laser emitting at 488 nm was used to quantify cell fluorescence. Viable cells were gated on the basis of both forward and 90" light scatter. FL emission was measured by filtering the light passed by the first dichroic mirror through a narrow band green filter (530 f 10 nm). PE and 7-AAD fluorescence were detected by sequential dichroic mirrors reflecting light of wavelengths longer than 640 nm. Electronic compensation was used to eliminate spectral overlap between FL and PE and between PE and 7-AAD. Ten thousand to 50,000 events were accumulated in list mode and later analyzed. 
RESULTS

In Situ Hybridization
As illustrated in Fig 1, MGKs express readily detectable levels of CD4 mRNA. A smaller mononuclear cell, presumably a T lymphocyte or monocyte, is also clearly positive. About 20% of morphologically identifiable MGKs (very large cells with prominent lobulated nuclei and abundant cytoplasm) were positive. When immunocytochemical staining was performed, both small (presumably early) and large size cells that were stained for the platelet/MGK surface antigen GPIIIa expressed CD4 mRNA. Platelets had no detectable CD4 mRNA.
Binding Experiments
Low-density human bone marrow cells, isolated from a Percoll density gradient, contain 14.4% k 9.7% MGKs (range, 4.9% to 34%). The MGK-enriched population was incubated with HIV-I in the presence and absence of inhibitors of the binding of HIV-lgpl20 to its CD4 receptor. In the absence of inhibition, HIV-I bound to 9.6% k 4.6% of cells (range, 3.0% to 18%).
Approximately two-thirds of the HIV-I-binding cells (6.8% k 3.8% of the total; range, 0.8% to 12%) were lymphocytes and monocytes because their light scatter pattern was characteristic of small hypogranular cells and they were not stained with CD4 1 (Fig 2, left lower panel) . Approximately one-third of the HIV-1-binding cells were MGKs, as judged by their light scatter pattern and positive reactivity with anti-CD4I (right upper and lower panels). Among MGKs (CD41+ cells), 23% f 17% bound HIV-1. This represents 2.8% k 1.8% of the total low-density bone marrow sample (range, 0.9% to 6.4%). Relative DNA content. panel), 32% t 5.5% at 1 pg/lOO pL (Table l) , and 55% at 10 pg/100 WL ( Table 2) . Similar inhibition was produced with soluble rCD4 (lower right panel; 71% 2 7%, Table I ). Anti-CD8 (Leu2a), a control antibody of the same class as Leu3a, produced no inhibition of HIV-I binding to low-density human bone marrow cells (upper right panel). In addition, no inhibition was noted with IgG F(ab), a protein of similar molecular weight as rCD4 (data not shown). The effect of these reagents on the binding of HIV-1 to CD4 1-cells is also illustrated in quadrant C of all four panels. The binding to small hypogranular cells (T cells and monocytes), not stained with CD4 1, is shown in quadrant A of all four panels. Incubation with anti-CD4 (lower left panel) inhibited 84% k 11% ofthe HIV-1 binding (Table I) . Similar inhibition(88% t 26%) was obtained with soluble rCD4 (lower right panel) ( Table I) .
The inhibition of binding of HIV-I by Leu3a and rCD4 was dose dependent, and maximal at 1 to 10 pg/IOO pL ( Table  2) . Almost all of the HIV-I binding to small hypogranular (CD4+/gp120-) cells could be blocked at 1 pg/mL, but only 55% to 75% of the binding to MGKs could be blocked. Figure 5 demonstrates the reactivity of Leu3a with CHRF-288 cells. CD4 appears to be present on most cells, but with relatively low intensity compared with CD4+ T cells.
CD4-Dependent Infection of CHRF-288 MGKs
Liquid hybridization of the amplified HIV-1 product to a P32-labeled probe showed the presence of HIV-I DNA in CHRF-288 cells incubated with cell-free HIV-1. Preincubation of CHRF-288 with Leu3a antibody before exposure to HIV-1 resulted in inhibition of the signal derived from the amplified core (gag) DNA (Fig 6) . The infectivity of CHRF-288 cells is relatively low compared with that of HBP T cells.
HI V-lp24 production bv HI V-i,IIB-infected CHRF-288
MGKs. tection. Note the 65% to 70% inhibition of infection with Leu3a on days 9 and 7. respectively. CHRF-288 cells produced 13%) of the p24 produced by HBP T cells.
DISCUSSION
We have previously shown that human MGKs have serologically detectable CD4 on their surface." We now show that these cells express the mRNA that encodes the CD4 ." CHRF-288 cells are also reported to be "remarkably homogeneous" in both karyotype and marker expression: 95% of the cells express GPllb-GPlIla and PF4.I' CD4 was first identified as a differentiation antigen of Thelper cells. in which it is believed to be one of the accessory molecules that make up the T-cell receptor complex. On these cells it is thought to serve the dual function of promoting the adhesive interaction of T cells with antigen-presenting cells and transducing an independent intracellular signal. Signal transduction requires association with a phosphokinase.
The CD4 antigen is present on hematopoietic cells outside the T-cell lineage: circulating monocytes.'"-" eosinophils." MGKs," and some myeloid tumorsz3 We have been unable 
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